Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Progressive Insurance® Extends Relationship with Mitchell Through Long-Term Contract Renewal
SAN DIEGO, Calif.—Mitchell, a leader of auto physical damage technology solutions, today a
Workers' Comp
Article
Ask The Pharmacist: Medication Step Therapy in Workers’ Compensation
Why do some medications need to be tried before others can be approved?
Business Insurance
In the News
Networks shift from cost tool to care driver in workers comp
Workers' Comp
Case Study
How a Large National Insurer Strengthened Utilization Review Oversight of FRPs in California
Workers' Comp
Article
Turning Claims Data Into Actionable Insight
See What’s Working. Fix What’s Not. Faster.You manage complex programs. You’re responsible for outcomes.
Auto Physical Damage
News Release
Enlyte Completes Acquisition of PartsTrader
Investment strengthens PartsTrader’s open procurement platform across the collision repair ecosystem SAN DIEGO – Apr